Maze Therapeutics (NASDAQ:MAZE) Now Covered by Analysts at Mizuho

Maze Therapeutics (NASDAQ:MAZE) Now Covered by Analysts at Mizuho

Mizuho assumed coverage on shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) in a research report sent to investors on Tuesday, MarketBeat reports. The brokerage issued an outperform rating and a $97.00 price target on the stock. Other analysts have also issued reports about the stock. Wells Fargo & Company initiated coverage on shares of Maze Therapeutics in a research note on Thursday, December 4th. They set an “overweight” rating and a …